Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
537.65
-9.14 (-1.67%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Madrigal Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $542 → $553 | Hold | Reiterates | $542 → $553 | +2.86% | Jul 22, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $644 | Buy | Maintains | $644 | +19.78% | Jul 22, 2026 |
| UBS | UBS | Buy Maintains $669 | Buy | Maintains | $669 | +24.43% | Jul 21, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $737 → $739 | Buy | Maintains | $737 → $739 | +37.45% | Jul 17, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 14, 2026 |
| Barclays | Barclays | Buy Maintains $964 | Buy | Maintains | $964 | +79.30% | Jul 13, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $600 | Buy | Maintains | $600 | +11.60% | Jun 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $900 | Buy | Maintains | $900 | +67.40% | Jun 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.